knowledge -WSS

knowledge

author：comprehensive 2025-10-01 21:36:56 - browse：53153

green electrocardiogram scan. -- health tech coverage from STAT — Adobe

As Bristol Myers Squibb works to build its treatment for a heart condition that can cause difficulty breathing into a blockbuster drug, it’s propped up an algorithm designed to help find more people who are affected.

The algorithm, which is part of software developed by Viz.ai, earlier this month received clearance from the Food and Drug Administration. The tool, called Viz HCM, looks at 12-lead electrocardiograms collected during routine care and flags suspected cases of hypertrophic cardiomyopathy, or HCM, for further evaluation. As part of a multi-year agreement between the companies, BMS — whose drug, Camzyos, is used to treat HCM — provided funding and scientific input for the development of the algorithm.

“BMS has a vested interest in finding more patients with HCM,” said Matthew Martinez, a cardiologist who leads Viz.ai’s HCM medical advisory board. “Why? Because they’re so philanthropic? No, they want to sell more drugs. They want to help more people by identifying more people.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： H5N1 bird flu virus started spreading in cows in Texas in December

WSS

Orangutan used medicinal plant to treat wound, first time ever seen

FTC falls short on scrutinizing hospital mergers, study says

Close Medicare's dangerous gaps in addiction treatment coverage

Curing rare childhood diseases will falter unless Congress steps up

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

Element Biosciences CEO lays out genome sequencing strategy

focus

knowledge

Wikipedia

Jerome Adams on the need for new antivirals for Covid

STAT Virtual Event: ASCO Recap, Live!

Dobbs anniversary: the lost opportunity of abortion as health care

After traumatic brain injury, life support decisions can use more time

Cancer drug shortages should be causing more outrage

Health care court cases: Humana, Sutter, Novant

Guidelines to prevent youth baseball injuries need more muscle

UnitedHealth financials solid despite Change Healthcare cyberattack

Moonlake's readout produced a cash windfall. Risks remain

FTC falls short on scrutinizing hospital mergers, study says

explore

Readers discuss the intersection of pregnancy and addiction

Coercive sterilizations revealed by STAT prompt outrage

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

Cue Health's Covid

Cell therapy fails to slow type 1 diabetes, but safety is established

Statins may not be needed by millions of people, study suggests

focus

explore

hotspot

focus